Videos Archives - European Biotechnology Magazine

Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Comments

This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Comments

This field is for validation purposes and should be left unchanged.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
- Issues
- Special
- Subscribe
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

POWTECH TECHNOPHARM

About POWTECH TECHNOPHARM

slider, Sponsored Publications, Videos

POWTECH TECHNOPHARM (Nuremberg, 23-25 September 2025) is the international trade fair for process engineering experts and a tailor-made technology platform for the pharmaceutical and life science industries.

23 August 2025

https://european-biotechnology.com/wp-content/uploads/2025/08/PT23-Entrance_NurnbergMesse_Thomas-Geiger-1.jpg 540 960 h.genrich /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png h.genrich2025-08-23 09:12:512025-08-26 09:58:10About POWTECH TECHNOPHARM

LATEST NEWS

MoA of BioArtic's brain transporter technology that improved antibody uptake 70-fold in preclinical tests

BioArctic AB

Novartis secures US$30m+ licence option from BioArc...

Esai Pharma

Alzheimer’s antibody Lecanemab launched in the EU

EFPIA

US and EU confirm tariff deal on pharmaceuticals, g...

MAGAZINE

1 / 4

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

2 / 4

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

3 / 4

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

4 / 4

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

❮❯